Identification of high-risk patients in multiple myeloma using a clonal gene signature

被引：0
|
作者：
Li, Jian-Rong
Wang, Christiana
Cheng, Chao
机构：
来源：
CANCER RESEARCH | 2023年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-7663
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7663
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Clonal plasma cell proportion in the synthetic phase identifies a unique high-risk cohort in multiple myeloma
    Saurabh Zanwar
    Dragan Jevremovic
    Prashant Kapoor
    Horatiu Olteanu
    Francis Buadi
    Pedro Horna
    Wilson Gonsalves
    Gregory Otteson
    Abiola Bukunmi Bolarinwa
    Suzanne Hayman
    Nadine Abdallah
    Moritz Binder
    Joselle Cook
    Angela Dispenzieri
    David Dingli
    Morie A. Gertz
    Taxiarchis Kourelis
    Nelson Leung
    Yi Lin
    Eli Muchtar
    Rahma Warsame
    Amie Fonder
    Miriam Hobbs
    Yi Lisa Hwa
    Michelle Rogers
    Robert A. Kyle
    S. Vincent Rajkumar
    Shaji Kumar
    Blood Cancer Journal, 15 (1)
  • [42] Identification and Molecular Characterization of High-Risk Multiple Myeloma Patients from the MMRF CoMMpass Study at Diagnosis and Progression
    Skerget, Sheri
    Christofferson, Austin
    Nasser, Sara
    Legendre, Christophe
    Yesil, Jennifer
    Auclair, Daniel
    Lonial, Sagar
    Keats, Jonathan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E7 - E7
  • [43] A prognostic gene-signature based identification of high-risk thin melanomas.
    Koelblinger, Peter
    Levesque, Mitchell P.
    Kaufmann, Corina
    Sulberg, Heiko
    Hinke, Axel
    Hoffmann, Marie-Christine
    Brunner, Georg
    Dummer, Reinhard
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [44] Identification of patients at high risk of secondary extramedullary multiple myeloma development
    Stork, Martin
    Sevcikova, Sabina
    Minarik, Jiri
    Krhovska, Petra
    Radocha, Jakub
    Pospisilova, Lenka
    Brozova, Lucie
    Jarkovsky, Jiri
    Spicka, Ivan
    Straub, Jan
    Pavlicek, Petr
    Jungova, Alexandra
    Jelinek, Tomas
    Sandecka, Viera
    Maisnar, Vladimir
    Hajek, Roman
    Pour, Ludek
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 196 (04) : 954 - 962
  • [45] Identification of a Gene Signature Associated to Treatment Response to Palbociclib in Multiple Myeloma
    Bruyer, Angelique
    Kassambara, Alboukadel
    Anziani, Paul
    El Bahlagui, Donia
    Robert, Nicolas
    Vincent, Laure
    Klein, Bernard
    Moreaux, Jerome
    BLOOD, 2016, 128 (22)
  • [46] Safety and efficacy of bortezomib in high-risk and elderly patients with relapsed multiple myeloma
    Richardson, Paul G.
    Sonneveld, Pieter
    Schuster, Michael W.
    Irwin, David
    Stadtmauer, Edward A.
    Facon, Thierry
    Harousseau, Jean-Luc
    Ben-Yehuda, Dina
    Lonial, Sagar
    San Miguel, Jesus-F.
    Cavenagh, Jamie D.
    Anderson, Kenneth C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 (05) : 429 - 435
  • [47] Ultra high-risk myeloma: definition, identification, management
    Avet-Loiseau, Herve
    Minvielle, Stephane
    Moreau, Philippe
    HEMATOLOGIE, 2011, 17 (02): : 145 - 149
  • [48] Current Approach to Managing Patients with Newly Diagnosed High-Risk Multiple Myeloma
    Naimisha Marneni
    Rajshekhar Chakraborty
    Current Hematologic Malignancy Reports, 2021, 16 : 148 - 161
  • [49] Real-world Outcomes of Chinese patients with high-risk Multiple Myeloma
    Sui Weiwei
    Deng, Shuhui
    An, Gang
    Xu, Yan
    Hao, Mu
    Mao, Xuehan
    Zou, De-Hui
    Qiu, Lugui
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E222 - E222
  • [50] Spinal metastases in multiple myeloma: A high-risk subgroup for ISS III patients
    Cossu, Giulia
    Terrier, Louis-Marie
    Benboubker, Lotfi
    Destrieux, Christophe
    Velut, Stephane
    Francois, Patrick
    Zemmoura, Ilyess
    Amelot, Aymeric
    SURGICAL ONCOLOGY-OXFORD, 2018, 27 (02): : 321 - 326
12345